SCHEMBL13664762

SCHEMBL13664762

C=C(N)/N=C(\C)N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13076412 0.84 TDP1 (0.32)
SCHEMBL20808577 0.79
SCHEMBL24625541 0.79
SCHEMBL16378625 0.79
SCHEMBL21263777 0.76
SCHEMBL18378601 0.73
SCHEMBL18757731 0.73
SCHEMBL14153090 0.73
SCHEMBL20934679 0.71
SCHEMBL18773490 0.71 TDP1 (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11530314-B2 Method for manufacturing both organic-inorganic composite synthetic resin containing highly flame-retardant organically modified nanoparticle and processed product thereof KYUNG DONG ONE CORPORATION (KR) 2022-12-20 US disclosed
WO-2016112120-A1 COMPOUNDS FOR TREATMENT OF CYSTIC FIBROSIS THE CALIFORNIA INSTITUTE FOR BIOMEDICAL RESEARCH (US) 2016-07-14 WO disclosed
WO-2015076801-A1 SUBSTITUTED TRIAZINE BMI-1 INHIBITORS PTC THERAPEUTICS, INC. (US) 2015-05-28 WO disclosed
WO-2013032591-A1 HETEROCYCLIC COMPOUNDS AND USES THEREOF INFINITY PHARMACEUTICALS INC. (US) 2013-03-07 WO disclosed
WO-2009126841-A1 ENZYMATIC BIOSENSORS WITH ENHANCED ACTIVITY RETENTION FOR DETECTION OF ORGANIC COMPOUNDS COLORADO STATE UNIVERSITY RESEARCH FOUNDATION (US) 2009-10-15 WO disclosed